Company
United StatesStemCure, Inc., Brooklyn, NY – FDA Inspections
Inspection records and compliance data for StemCure, Inc. in Brooklyn, New York. 3 FDA inspections on record, last inspected November 07, 2022.
Company Profile
This profile covers StemCure, Inc. based in Brooklyn, New York, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected December 3, 2015. Last inspected November 7, 2022.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 7, 2022 | NAI | Biologics · Vaccines and Allergenic Products | 1187512 |
| May 8, 2018 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1052724 |
| December 3, 2015 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 953354 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
StemCure, Inc.
FEI Number
3010642819
Address
164 20th St Ste 2D, Brooklyn, New York 11232, United States
Country
United States
ID: 7b6ef27b-1bb9-44bc-b610-4a66a001d7a8